Casini A, Geppetti P, Maggi C A, Surrenti C
Department of Clinical Pathophysiology, University of Florence, Italy.
Naunyn Schmiedebergs Arch Pharmacol. 1989 Mar;339(3):354-8. doi: 10.1007/BF00173591.
(1) We have studied the ability of some regulatory peptides to induce a mitogenic (incorporation of tritiated thymidine) response in human peripheral blood mononuclear cells (PBMC) and to modify the response produced by phytohaemagglutinin (PHA), a well known PBMC mitogen. (2) Human calcitonin gene-related peptide (hCGRP), human or salmon calcitonin (hCT, sCT), neurokinin A (NKA) and neurokinin (4-10) (up to 1 microM for each peptide) did not produce per se any significant PBMC stimulation. (3) hCGRP (0.1 nM-1 microM) produced a concentration dependent enhancement of the response to a submaximal concentration of PHA (1 microgram/ml). On the other hand, hCGRP decreased the mitogenic response to a maximal concentration of PHA (25 micrograms/ml). (4) Neither hCT nor sCT (0.1 nM-1 microM) had a significant influence on the response to PHA (1-25 micrograms/ml). (5) Both NKA and NKA (4-10) produced a concentration-dependent (1 fM-10 pM) enhancement of the response to 1 microgram/ml PHA, while these compounds had no effect on the response to 25 micrograms/ml PHA. (6) These findings suggest a potent modulatory action of CGRP and NKA, two peptides present in sensory and other nerves, on immune function which is possibly mediated via C2 receptors for CGRP and NK-2 tachykinin receptors, respectively.
(1) 我们研究了一些调节肽在人外周血单个核细胞(PBMC)中诱导有丝分裂(氚标记胸腺嘧啶核苷掺入)反应的能力,以及对植物血凝素(PHA,一种众所周知的PBMC有丝分裂原)所产生反应的调节作用。(2) 人降钙素基因相关肽(hCGRP)、人或鲑鱼降钙素(hCT、sCT)、神经激肽A(NKA)和神经激肽(4 - 10)(每种肽浓度高达1微摩尔)本身并未产生任何显著的PBMC刺激作用。(3) hCGRP(0.1纳摩尔 - 1微摩尔)对亚最大浓度的PHA(1微克/毫升)所产生的反应有浓度依赖性增强作用。另一方面,hCGRP降低了对最大浓度PHA(25微克/毫升)的有丝分裂反应。(4) hCT和sCT(0.1纳摩尔 - 1微摩尔)对PHA(1 - 25微克/毫升)的反应均无显著影响。(5) NKA和神经激肽(4 - 10)对1微克/毫升PHA所产生的反应均有浓度依赖性(1飞摩尔 - 10皮摩尔)增强作用,而这些化合物对25微克/毫升PHA的反应无影响。(6) 这些发现提示,感觉神经和其他神经中存在的两种肽,即CGRP和NKA,对免疫功能有强大的调节作用,可能分别通过CGRP的C2受体和NK - 2速激肽受体介导。